Literature DB >> 28074610

An in vitro model yields 'importin' new insights into chronic traumatic encephalopathy: damaged astrocytes stop 'thrombospondin' to the injury: An Editorial Highlight for 'Defective synthesis and release of astrocytic thrombospondin-1 mediates the neuronal TDP-43 proteinopathy, resulting in defects in neuronal integrity associated with chronic traumatic encephalopathy: in vitro studies'.

Sausan M Jaber1,2, Brian M Polster1,2.   

Abstract

Read the highlighted article 'Defective synthesis and release of astrocytic thrombospondin-1 mediates the neuronal TDP-43 proteinopathy, resulting in defects in neuronal integrity associated with chronic traumatic encephalopathy: in vitro studies' on page 645.
© 2017 International Society for Neurochemistry.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28074610      PMCID： PMC5296284          DOI： 10.1111/jnc.13906

Source DB:  PubMed          Journal:  J Neurochem        ISSN： 0022-3042            Impact factor:   5.372


  11 in total

1.  TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy.

Authors:  Ann C McKee; Brandon E Gavett; Robert A Stern; Christopher J Nowinski; Robert C Cantu; Neil W Kowall; Daniel P Perl; E Tessa Hedley-Whyte; Bruce Price; Chris Sullivan; Peter Morin; Hyo-Soon Lee; Caroline A Kubilus; Daniel H Daneshvar; Megan Wulff; Andrew E Budson
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

2.  Purinergic signaling induces thrombospondin-1 expression in astrocytes.

Authors:  Minh D Tran; Joseph T Neary
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

3.  Defective synthesis and release of astrocytic thrombospondin-1 mediates the neuronal TDP-43 proteinopathy, resulting in defects in neuronal integrity associated with chronic traumatic encephalopathy: in vitro studies.

Authors:  Arumugam Radhakrishnan Jayakumar; Xiao Y Tong; Nagarajarao Shamaladevi; Stephanie Barcelona; Gabriel Gaidosh; Apeksha Agarwal; Michael D Norenberg
Journal:  J Neurochem       Date:  2017-01-10       Impact factor: 5.372

Review 4.  Animal models of sports-related head injury: bridging the gap between pre-clinical research and clinical reality.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Nieves Herrera-Mundo; David C Viano; Donald M Kuhn
Journal:  J Neurochem       Date:  2014-03-19       Impact factor: 5.372

5.  Chronic cerebral ischemia induces redistribution and abnormal phosphorylation of transactivation-responsive DNA-binding protein-43 in mice.

Authors:  Akihiro Shindo; Kenichiro Yata; Ryogen Sasaki; Hidekazu Tomimoto
Journal:  Brain Res       Date:  2013-08-14       Impact factor: 3.252

6.  Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice.

Authors:  Ya-Fei Xu; Tania F Gendron; Yong-Jie Zhang; Wen-Lang Lin; Simon D'Alton; Hong Sheng; Monica Castanedes Casey; Jimei Tong; Joshua Knight; Xin Yu; Rosa Rademakers; Kevin Boylan; Mike Hutton; Eileen McGowan; Dennis W Dickson; Jada Lewis; Leonard Petrucelli
Journal:  J Neurosci       Date:  2010-08-11       Impact factor: 6.167

7.  Na-K-Cl cotransporter-1 in the mechanism of cell swelling in cultured astrocytes after fluid percussion injury.

Authors:  Arumugam R Jayakumar; Kiran S Panickar; Kevin M Curtis; Xiao Y Tong; Mitsuaki Moriyama; Michael D Norenberg
Journal:  J Neurochem       Date:  2011-03-14       Impact factor: 5.372

8.  α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease.

Authors:  Roberto Di Maio; Paul J Barrett; Eric K Hoffman; Caitlyn W Barrett; Alevtina Zharikov; Anupom Borah; Xiaoping Hu; Jennifer McCoy; Charleen T Chu; Edward A Burton; Teresa G Hastings; J Timothy Greenamyre
Journal:  Sci Transl Med       Date:  2016-06-08       Impact factor: 17.956

9.  Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease.

Authors:  Andrew King; Fiona Sweeney; Istvan Bodi; Claire Troakes; Satomi Maekawa; Safa Al-Sarraj
Journal:  Neuropathology       Date:  2010-01-19       Impact factor: 1.906

10.  The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity.

Authors:  Wenzhang Wang; Luwen Wang; Junjie Lu; Sandra L Siedlak; Hisashi Fujioka; Jingjing Liang; Sirui Jiang; Xiaopin Ma; Zhen Jiang; Edroaldo Lummertz da Rocha; Max Sheng; Heewon Choi; Paul H Lerou; Hu Li; Xinglong Wang
Journal:  Nat Med       Date:  2016-06-27       Impact factor: 53.440
View more
  2 in total

Review 1.  Brain Injury-Mediated Neuroinflammatory Response and Alzheimer's Disease.

Authors:  Duraisamy Kempuraj; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Ramasamy Thangavel; Arshdeep S Dhaliwal; Iuliia Dubova; Shireen Mentor; Keerthivaas Premkumar; Daniyal Saeed; Haris Zahoor; Sudhanshu P Raikwar; Smita Zaheer; Shankar S Iyer; Asgar Zaheer
Journal:  Neuroscientist       Date:  2019-05-16       Impact factor: 7.519

Review 2.  Hyperammonemia in Hepatic Encephalopathy.

Authors:  A R Jayakumar; Michael D Norenberg
Journal:  J Clin Exp Hepatol       Date:  2018-06-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.